Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series

American Journal of Medicine

Volumn 123, Issue 11, 2010, Pages 1060-1064

  Fedele, Stefano ^a   Porter, Stephen R ^a   D'Aiuto, Francesco ^a   Aljohani, Suad ^a   Vescovi, Paolo ^b   Manfredi, Maddalena ^b   Arduino, Paolo G ^c   Broccoletti, Roberto ^c   Musciotto, Anna ^d   Di Fede, Olga ^d   Lazarovici, Tony S ^e   Campisi, Giuseppina ^d   Yarom, Naom ^e,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e SHEBA MEDICAL CENTER   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

Avascular necrosis; Bisphosphonates; Jawbones; Jaws; Mandible; Maxilla; Osteochemonecrosis; Osteonecrosis

Indexed keywords

ALENDRONIC ACID; CLODRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE PAIN; BREAST CANCER; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG EXPOSURE; EUROPE; FEMALE; GINGIVA DISEASE; HUMAN; JAW OSTEONECROSIS; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER; THERAPY EFFECT; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; EUROPE; FEMALE; HUMANS; JAW DISEASES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEONECROSIS; OSTEOPOROSIS; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 78049445662     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.04.033     Document Type: Article

References (23)

1. C.A. Migliorati, M.A. Siegel, and L.S. Elting Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment Lancet Oncol 7 2006 508 514 (Erratum in: Lancet Oncol. 2006;7:533)
2. S.L. Silverman, and R. Landesberg Osteonecrosis of the jaw and the role of bisphosphonates: a critical review Am J Med 122 2009 S33 S45
3. S.B. Woo, J.W. Hellstein, and J.R. Kalmar Narrative (corrected) review: bisphosphonates and osteonecrosis of the jaws Ann Intern Med 144 2006 753 761 (Erratum in: Ann Intern Med. 2006;145:235)
4. B.J. Edwards, M. Gounder, and J.M. McKoy Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw Lancet Oncol 9 2008 1166 1172
5. Research on Adverse Drug Reactions and Reporting (RADAR) Bisphosphonate associated osteonecrosis of the jaw: FDA AERS search http://cancer.northwestern. edu/radar/yearsONJforradarwebsite.pdf Accessed December 13, 2009
6. K. Vahtsevanos, A. Kyrgidis, and E. Verrou Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw J Clin Oncol 27 2009 5356 5362
7. T. Boonyapakorn, I. Schirmer, and P.A. Reichart Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies Oral Oncol 44 2008 857 869
8. A. Bamias, E. Kastritis, and C. Bamia Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol 23 2005 8580 8587
9. A. Badros, E. Terpos, and E. Katodritou Natural history of osteonecrosis of the jaw in patients with multiple myeloma J Clin Oncol 26 2008 5904 5909
10. A. Kyrgidis, and K. Vahtsevanos Osteonecrosis of the jaw in patients receiving oral bisphosphonates Osteoporos Int 21 2010 535 536
11. L.A. Assael Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies J Oral Maxillofac Surg 67 2009 35 43
12. M. Pazianas, P. Miller, W.A. Blumentals, M. Bernal, and P. Kothawala A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics Clin Ther 29 2007 1548 1558
13. R.E. Marx, Y. Sawatari, and M. Fortin Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567 1575
14. J.V. Bagan, Y. Jimenez, and J.M. Diaz Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification Oral Oncol 45 2009 645 646
15. H. Mawardi, N. Treister, and P. Richardson Sinus tractsan early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 67 2009 593 601
16. L. Junquera, and L. Gallego Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? J Oral Maxillofac Surg 66 2008 1516 1517
17. K.N. Malizos, A.H. Karantanas, and S.E. Varitimidis Osteonecrosis of the femoral head: etiology, imaging and treatment Eur J Radiol 63 2007 16 22
18. K.L. Harreld, D.R. Marker, and E.R. Wiesler Osteonecrosis of the humeral head J Am Acad Orthop Surg 17 2009 345 355
19. M.R. Allen, D.J. Kubek, and D.B. Burr Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs J Bone Miner Res 25 1 2010 98 105
20. D.B. Burr, and M.R. Allen Mandibular necrosis in beagle dogs treated with bisphosphonates Orthod Craniofac Res 12 2009 221 228
21. American Dental Association Council on Scientific Affairs Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendationsreport of the Council on Scientific Affairs www.ada.org/prof/ resources/topics/topics-osteonecrosis-bisphosphonate-report.pdf Accessed November 13, 2009
22. S.L. Ruggiero, T.B. Dodson, and L.A. Assael American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws2009 update J Oral Maxillofac Surg 67 2009 2 12
23. R.E. McMahon, J.E. Bouquot, and C.J. Glueck Staging bisphosphonate- related osteonecrosis of the jaw should include early stages of disease J Oral Maxillofac Surg 65 2007 1899 1900